Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...

(Reuters) -Novo Nordisk on Tuesday appointed insider Mike Doustdar as its new chief executive after the Danish obesity drug maker cut its full year outlook for the second time in 2025, sending its ...